Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021)

Background: Coronavirus 2019 (COVID-19) vaccination is recommended for people with multiple sclerosis (MS). This study evaluated the side effects of Sinopharm and AstraZeneca vaccines in MS patients. Methods: In this cross-sectional study among MS patients in Kermanshah province, Iran, who received...

Descripción completa

Detalles Bibliográficos
Autores principales: Razazian, Nazanin, Sahraian, Mohammad Ali, Rezaei, Mansour, Eskandarieh, Sharareh, Khamoushian, Kianoosh, Mousavi, Seyede Elham, Fakhri, Negin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444592/
https://www.ncbi.nlm.nih.gov/pubmed/38011394
http://dx.doi.org/10.18502/cjn.v22i1.12611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444592/
https://www.ncbi.nlm.nih.gov/pubmed/38011394
http://dx.doi.org/10.18502/cjn.v22i1.12611

Ejemplares similares